Last Price | 237.83 | Max Price | 249.87 |
Min Price | 213.62 | 1 Year return | 43.52 |
Sector | Health Care | Subsector | Health Care Eq. & Services |
Annual report 2016 |
Contact info:Street: Valley ForgeZip Code: 19482City: PennsylvaniaCountry: USAPhone: 6107277000Website: www.amerisourcebergen.comCEO: Steven H. CollisCFO: Tim G. Guttman
Year | Turnover | Total sector | Market share |
---|---|---|---|
2019 | 179,589 | 2,019,579 | 8.89 % |
2020 | 189,894 | 2,170,517 | 8.75 % |
2021 | 213,989 | 2,404,876 | 8.90 % |
2022 | 238,587 | 2,645,792 | 9.02 % |
2023 | 0 | 0 | 0.00 % |
No Records Found
Analysts expect over 2021 rising revenue AmerisourceBergen
Analysts: more sales AmerisourceBergen
2017 record year for AmerisourceBergen
2017 | 2018 | 2019 | 2020 | 2021 |
---|---|---|---|---|
Over the past year the company' stock lost around 22 percent. The period between August 2011 and August 2016 was a profitable period for the investors. The stock rose on average 115 percent. AmerisourceBergen's revenues between 2011 and 2015 were quite unstable and moved between 79,49 billion dollars and 135,96 billion dollars. AmerisourceBergen's net results between 2011 and 2015 were far from constant and moved between 706,62 million dollars and -134,89 million dollars.
The company's head quarter is located in Pennsylvania. The company mostly operates in the pharmaceutical sector. AmerisourceBergen is leaded by CEO Steven H. Collis Tim G. Guttman leads the company as CFO. Between 2006 and 2016 the global pharmaceutical companies gained around 75 percent. Over the past 5 years the sector is 147 percent higher.
The American company paid out dividends in the past 5 years. Over the past 5 years the stock delivered an average dividend return of 3,89 percent. Over the past 5 years the company raised it's dividends each year. So we could call AmerisourceBergen a kind of dividend aristocrat.
At the end of 2015 the American company had a balance sheet of 27,74 billion dollars. 27,1 billion dollars (97,72 percent of the total balance sheet) was financed by debt. Last year the pharmaceutical company's price/earnings-ratio (PE) was around -410. So the investors valued the stock at -410 times 2015' earnings per share. We could say that based on her price/earnings-ratio and dividend yield the American stock can be seen as a value stock.
At the end of 2015 the pharmaceutical company's market size (her number of outstanding share times the stock price) equaled around 21,11 billion dollars. At the end of 2015 the American company had around 206,89 million stocks listed.
All AmerisourceBergen's annual reports can be found here. More information about AmerisourceBergen can be found it's website. .
Results |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|---|
Revenue |
135,962
|
146,850
|
153,144
|
167,940
|
179,589
|
189,894
|
Costs |
136,100
|
145,422
|
152,779
|
166,282
|
178,734
|
193,303
|
Profit |
-138
|
1,428
|
364
|
1,658
|
855
|
-3,409
|
Margin of profit |
-0.10
|
0.97
|
0.24
|
0.99
|
0.48
|
-1.80
|
ROI |
-22.42
|
67.06
|
17.65
|
56.55
|
29.71
|
334.54
|
Balance |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|---|
Equity |
616
|
2,129
|
2,064
|
2,933
|
2,879
|
-1,019
|
Debt |
27,347
|
31,508
|
33,252
|
34,737
|
36,293
|
45,294
|
Total assets |
27,963
|
33,638
|
35,316
|
37,670
|
39,172
|
44,275
|
Solvency |
2.20
|
6.33
|
5.85
|
7.79
|
7.35
|
-2.30
|
Cash |
2,167
|
2,742
|
2,435
|
2,493
|
3,374
|
4,598
|
Cashflow |
3,922
|
3,179
|
1,504
|
1,411
|
2,344
|
2,207
|
Employees |
0
|
0
|
0
|
0
|
0
|
|
Revenue per employee |
0.0
|
0.0
|
0.0
|
0.0
|
0.0
|
|
Cashflow / Debt |
0.14
|
0.10
|
0.05
|
0.04
|
0.06
|
0.05
|
Details |
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|
Price |
103.71
|
78.19
|
91.82
|
74.40
|
85.02
|
Eps |
6.32
|
1.64
|
7.53
|
4.04
|
-16.65
|
Price/earnings-ratio |
16.41
|
47.68
|
12.19
|
18.42
|
-14.28
|
Dividend |
1.36
|
1.46
|
1.52
|
1.60
|
1.66
|
Dividend % |
1.31 %
|
1.87 %
|
1.66 %
|
2.15 %
|
0.70 %
|
Payout % |
0.22
|
0.89
|
0.20
|
0.40
|
-0.10
|
Book value |
9.68
|
9.47
|
13.76
|
13.92
|
-4.99
|
Market to book |
0.09
|
0.12
|
0.15
|
0.19
|
-0.02
|
Cashflow per stock |
14.44
|
6.90
|
6.62
|
11.34
|
10.81
|
Stocks |
220
|
218
|
213
|
207
|
204
|
Market Cap |
22.821.44
|
17.044.92
|
19.577.68
|
15.383.02
|
48.571.07
|
Date
|
Price
|
---|---|
09 Jan 2025
|
237.83
|
17 Dec 2024
|
229.82
|
10 Dec 2024
|
240.51
|
06 Dec 2024
|
244.31
|
03 Dec 2024
|
249.87
|
29 Nov 2024
|
249.69
|
27 Nov 2024
|
248.45
|
13 Nov 2024
|
248.79
|
08 Nov 2024
|
247.76
|
05 Nov 2024
|
233.89
|
31 Oct 2024
|
229.48
|
29 Oct 2024
|
233.57
|
23 Oct 2024
|
234.17
|
19 Oct 2024
|
237.43
|
16 Oct 2024
|
233.12
|
14 Oct 2024
|
222.56
|
05 Oct 2024
|
219.94
|
02 Oct 2024
|
224.23
|
27 Sep 2024
|
223.88
|
20 Sep 2024
|
226.56
|
17 Sep 2024
|
241.24
|
13 Sep 2024
|
237.65
|
28 Aug 2024
|
233.50
|
26 Aug 2024
|
237.74
|
23 Aug 2024
|
240.59
|
11 Aug 2024
|
237.77
|
07 Aug 2024
|
241.10
|
05 Aug 2024
|
247.57
|
01 Aug 2024
|
237.88
|
30 Jul 2024
|
227.18
|